These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Liver damage in the course of phenothiazine treatment. Salac M; Svestka J Act Nerv Super (Praha); 1965 Aug; 7(3):250. PubMed ID: 5882097 [No Abstract] [Full Text] [Related]
46. Cholestatic jaundice during imipramine therapy. Short MH; Burns JM; Harris ME JAMA; 1968 Nov; 206(8):1791-2. PubMed ID: 5754834 [No Abstract] [Full Text] [Related]
47. Preventive effect of riboflavin and ATP on the teratogenic effects of the phenothiazine derivative T-82. Horvath C; Szonyi L; Mold K Teratology; 1976 Oct; 14(2):167-70. PubMed ID: 982312 [TBL] [Abstract][Full Text] [Related]
49. "Miscellaneous" side effects during prolonged phenothiazine therapy. Zabors TE Wis Med J; 1967 Feb; 66(2):115-7. PubMed ID: 5342511 [No Abstract] [Full Text] [Related]
50. Experimental potentiation of phenothiazine toxicology. I. Effect of livers disorders. Roizin L; Gold G; Kaufman MA; Fieve R; Alexander G; Ueno Y; Liu J; Keoseian S; Gray R Agressologie; 1968; 9(2):379-81. PubMed ID: 5675501 [No Abstract] [Full Text] [Related]